ELEKTA

History

YearDetail
1972 Elekta was founded in 1972 by Lars Leksell and his son Laurent Leksell to commercialize the Leksell Stereotactic System and the Gamma Knife.
1997 Elekta acquired the radiotherapy business from Philips and paid approximately $60 million in cash and shares.
2006 Elekta acquired IMPAC, a provider of information systems for managing radiation and medical oncology and related clinical practices.
2010 Elekta acquired Resonant Medical Inc., adding new solutions for image-guided radiation therapy for treating cancer.
2014 Toshiba Medical Systems Corporation (TMSC) collaborated with Elekta to obtain wider distribution rights for linear accelerator (linac) sales and expand its oncology systems and related software solutions in Japan.
2017 BESA GmbH partnered with Elekta to jointly develop and commercialize clinical software solutions for magnetoencephalography for the pre-surgical evaluation of epileptic patients.
2018 Allegheny Health Network (AHN), a Highmark Health Company, purchased Elekta products and services as the complete solution for its radiation oncology needs at Saint Vincent Hospital, Forbes Hospital, AHN Cancer Institute-Butler, and AHN Cancer Institute-Beaver.
2021 Elekta acquired its Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Ticaret A.Ş., to improve Elekta’s market access in the region and strengthen its relationship with customers.
2023 Elekta acquired the Xoft business from iCAD, Inc., through an asset acquisition to offer electronic brachytherapy technology and expand its range of cancer treatment options.
2024 Elekta launched a new radiation therapy system, Elekta Evo, that features next-generation image quality and online adaptive capabilities for cancer treatments.
2025 Elekta collaborated with Azra AI, an end-to-end oncology workflow automation platform, to enhance cancer registry operations through automation and AI-powered data management.
AI Sentiment